普瑞眼科2025年业绩预亏收窄，新医院培育与政策影响受关注

Core Viewpoint - The company, Puri Eye Hospital, forecasts a revenue of 2.75 billion to 2.85 billion yuan for 2025, with a net profit loss estimated between 50 million to 69 million yuan, indicating a reduction in losses compared to the previous year [1][2]. Group 1: Financial Performance - The expected revenue for 2025 is between 2.75 billion and 2.85 billion yuan, while the net profit loss is projected to be between 50 million and 69 million yuan, showing an improvement in loss compared to 2024 [2]. - The official annual report will provide detailed financial data and business explanations [2]. Group 2: Project Development - Since 2023, the company has been advancing its "national chain + local integration" expansion strategy, opening over ten new ophthalmology medical institutions that are currently in the market cultivation phase [3]. - The new facilities incur significant fixed asset depreciation and personnel costs, creating temporary pressure on overall profits [3]. - The potential for scale effects to further reduce losses as revenue gradually increases is a point of interest [3]. Group 3: Business and Technology Development - In 2025, Puri Eye Hospital will be among the first institutions in the country to introduce the new generation of Carl Zeiss all-laser SMILE Pro technology for refractive surgery [4]. - The company will also focus on promoting femtosecond laser-assisted cataract surgery and other high-end solutions to optimize the business structure of refractive and cataract projects, aiming to enhance the average transaction value [4]. Group 4: Industry Policy and Environment - The national bulk procurement policy for artificial crystalline lenses has been fully implemented in 2025, along with reforms in medical insurance payment methods, which structurally impact the revenue and profit margins of the company's cataract projects [5]. - The evolution of policy factors is expected to remain a focal point of industry attention [5]. Group 5: Shareholder Pledge - As of February 6, 2026, the total pledge ratio of the company is 18.35%, with a total of 27.4612 million shares pledged across 10 transactions, indicating stability in recent data [6].